Inherited susceptibility colorectal cancer

Annual Review of Medicine

Volumn 56, Issue , 2005, Pages 539-554

  Rowley, Peter T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Familial adenomatous polyposis (FAP); Genetic counseling; Genetic testing; Hereditary nonpolyposis colorectal cancer (HNPCC); Molecular genetics

Indexed keywords

APC PROTEIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADENOMATOUS POLYP; CANCER EPIDEMIOLOGY; CANCER SCREENING; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; DIPLOIDY; DNA SEQUENCE; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HAPLOIDY; HEALTH CARE COST; HUMAN; IMMUNOHISTOCHEMISTRY; INHERITANCE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; ONSET AGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RELATIVE; REVIEW; UNITED STATES;

ADENOMATOUS POLYPOSIS COLI; BASE PAIR MISMATCH; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MICROSATELLITE REPEATS; MOLECULAR BIOLOGY;

EID: 11444254340     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.56.061704.135235     Document Type: Review

References (88)

1. Jemal A, Tiwari RC, Murray T, et al. 2004. Cancer statistics, 2004. Cancer J. Clin. 54: 8-29
2. Trimbath JD, Giardiello FM. 2002. Review article: genetic testing and counseling for hereditary colorectal cancer. Aliment. Pharmacol. Ther. 16:1843-57
3. Groden J, Thliveris A, Samowitz W, et al. 1991. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600
4. Kinzler KW, Nilbert MC, Su LK, et al. 1991. Identification of FAP locus genes from chromosome 5q21. Science 253:661-65
5. Nishisho I, Nakamura Y, Miyoshi Y, et al. 1991. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665-69
6. Giardiello FM, Brensinger JD, Petersen GM. 2001. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 121:198-213
7. Wennstrom J, Pierce ER, McKusick VA. 1974. Hereditary benign and malignant lesions of the large bowel. Cancer 34:850-57
8. Grady WM. 2003. Genetic testing for high-risk colon cancer patients. Gastroenterology 24:1574-94
9. Burt RW. 2000. Colon cancer screening. Gastroenterology 119:837-53
10. Gardner EJ. 1962. Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermal cysts. Am. J. Hum. Genet. 14:376-90
11. Giardiello FM, Brensinger JD, Luce MC, et al. 1997. Phenotypic expression in adenomatous polyposis families with mutation in the 5′ region of the adenomatous polyposis coli gene. Ann. Intern. Med. 126:514-19
12. Burt RW, Kuwada SK, Kerber R, et al. 1995. The predominance of proximal colonic neoplasms in attenuated adenomatous polyposis coli. Gastroenterology 108:A453 (Abstr.)
13. Laken SJ, Papadopoulos N, Petersen G, et al. 1999. Analysis of masked mutations in familial adenomatous polyposis. Proc. Natl. Acad. Sci. USA 96:2322-26
14. Laurent-Puig P, Beroud C, Soussi T. 1998. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 26:269-70
15. Spirio L, Olschwang S, Groden J, et al. 1993. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 75:951-57
16. Brensinger JD, Laken SJ, Luce MC, et al. 1998. Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutations in the APC gene. Gut 43:548-52
17. Olschwang S, Tiret A, Laurent-Puig P, et al. 1993. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 75:959-68
18. Caspari R, Olschwang S, Friedl W, et al. 1995. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum. Mol. Genet. 4:337-40
19. Laken SJ, Petersen GM, Gruber SB, et al. 1997. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat. Genet. 17:79-83
20. Woodage T, King SM, Wacholder S, et al. 1998. The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat. Genet. 20:62-65
21. Gryfe R, Di Nicola N, Lai G, et al. 1999. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am. J. Hum. Genet. 64:378-84
22. Mecklin JP. 1987. Frequency of hereditary colorectal carcinoma. Gastroenterology 93:1021-25
23. Scapoli C, Ponz deLeon M, Sassatelli R, et al. 1994. Genetic epidemiology of hereditary non-polyposis colorectal cancer syndromes in Modena, Italy: results of a complex segregation analysis. Ann. Hum. Genet. 58:275-95
24. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. 1997. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J. Natl. Cancer Inst. 89:1758-62
25. Aaltonen LA, Salovaara R, Kristo P, et al. 1998. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med. 338:1481-87
26. Lynch HT, Shaw MW, Magnuson CW, et al. 1966. Hereditary factors in two large Midwestern kindreds. Arch. Intern. Med. 117:206-12
27. Vasen HFA, Wijnen JT, Menko FH, et al. 1996. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020-27
28. Lynch HT, Smyrk TC, Watson P, et al. 1993. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104:1535-49
29. Gryfe R, Kim H, Hsieh ETK, et al. 2000. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N. Engl. J. Med. 342:69-77
30. Mitchell RJ, Farrington SM, Dunlop MG, et al. 2002. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am. J. Epidemiol. 156:885-902
31. Cruz-Correa M, Giardiello FM. 2002. Diagnosis and management of hereditary colon cancer. Gastroenterol. Clin. N. Am. 31:537-49
32. Vasen HFA, Offerhaus GJA, den Hartog Jager FCA, et al. 1990. The tumour spectrum in hereditary nonpolyposis colorectal cancer: a study of 24 kindreds in the Netherlands. Int. J. Cancer 46:31-34
33. Watson P, Lynch HT. 1993. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677-85
34. Aarnio M, Mecklin J-P, Aaltonen LA. 1995. Lifetime risk of different cancers in hereditary nonpolyposis colorectal cancer. Int. J. Cancer 64:430-33
35. Eng C, Hampel H, de la Chapelle A. 2000. Genetic testing for cancer predisposition. Annu. Rev. Med. 52:371-400
36. Jacob S, Praz F. 2002. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie 84:27-47
37. Buttin BM, Powell MA, Mutch DG, et al. 2004. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am. J. Hum. Genet. 74:1262-69
38. Liu T, Yan H, Kuismanen S, et al. 2001. The role of hPMS 1 and hPMS2 in predisposing to colorectal cancer. Cancer Res. 61:7798-802
39. Guerrette S, Acharya S, Fishel R. 1999. The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J. Biol. Chem. 274:6336-41
40. De Rosa M, Fasano C, Panariello L, et al. 2000. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene 19:1719-23
41. Kondo E, Horii A, Fukushige S. 2001. The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1, and hPMS2. Nucleic Acids Res. 29:1695-702
42. Viel A, Novella E, Genuardi M, et al. 1998. Lack of PMS2 gene-truncating mutations in patients with hereditary colorectal cancer. Int. J. Oncol. 13:565-69
43. Wang Q, Lasset C, Desseigne F, et al. 1999. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer. Hum. Genet. 105:79-85
44. Huang J, Kuismanen SA, Liu T, et al. 2001. MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. Cancer Res. 61:1619-23
45. Ohmiya N, Matsumoto H, Yamamoto S, et al. 2001. Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene 272:301-13
46. Lipkin SM, Wang V, Stoler DL, et al. 2001. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: evidence for somatic mutation in colorectal cancer. Hum. Mutat. 17:389-96
47. Liu H-X, Zhou X-L, Liu T, et al. 2003. The role of hMLH3 in familial colorectal cancer. Cancer Res. 63:1894-99
48. Vasen HFA, Mecklin J-P, MeeraKhan P, et al. 1991. The international collaborative group on hereditary nonpolyposis colorectal cancer (ICG-HNPCC). Dis. Colon Rectum 36:424-25
49. Umar A, Boland CR, Terdiman JP, et al. 2004. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 96:261-68
50. Lynch HT, de la Chapelle A. 2003. Hereditary colorectal cancer. N. Engl. J. Med. 348:919-32
51. Al-Tassan N, Chmiel NH, Maynard J, et al. 2002. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat. Genet. 30:227-32
52. Sieber OM, Lipton L, Crabtree M, et al. 2003. Multiple colorectal adenomas, classic adenomatous polyposis, and germline mutations in MYH. N. Engl J. Med. 348:791-99
53. Lynch HT, Lynch JF. 2000. Lynch syndrome: genetics, natural history, genetic counseling, and prevention. J. Clin. Oncol. 18:19s-31s
54. Wahlberg S, Liu T, Lindblom P, et al. 1999. Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and fcMLH1. Genet. Test. 3:259-64
55. Farrington SM, Lin-Goerke J, Ling J, et al. 1998. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am. J. Hum. Genet. 63:749-59
56. Thibodeau SN, Bren G, Schaid D. 1993. Microsatellite instability in cancer of the proximal colon. Science 260:816-19
57. Chen WS, Chen JY, Liu JM, et al. 1997. Microsatellite instability in sporadic-colon-cancer patients with and without liver metastases. Int. J. Cancer 74:470-74
58. Eshleman JR, Casey G, Kochera ME, et al. 1998. Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53. Oncogene 17:719-25
59. Ionov Y, Peinado MA, Malkhosyan S, et al. 1993. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-61
60. Kim H, Jen J, Vogelstein B, et al. 1994. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am. J. Pathol. 145:148-56
61. Boland CR, Thibodeau SN, Hamilton SR, et al. 1998. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58:5248-57
62. Dolcetti R, Viel A, Doglioni C, et al. 1999. High prevalence of activated intraepithelial cytotoxic T-lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am. J. Pathol. 154:1805-13
63. Ribic CM, Sargent DJ, Moore MJ, et al. 2003. Tumor microsatellite- instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 349:247-57
64. de la Chapelle A. 2003. Microsatellite instability. N. Engl. J. Med. 349:209-10
65. Frazier ML, Xi L, Zong J, et al. 2003. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res. 63:4805-8
66. Aaltonen LA, Peltomaki P, Mecklin J-P, et al. 1994. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res. 54:1645-48
67. Lynch HT, Smyrk TC. 1998. Identifying hereditary nonpolyposis colorectal cancer. N. Engl. J. Med. 338:1537-38
68. Bapat BV, Madlensky L, Temple LKF, et al. 1999. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum. Genet. 104:167-76
69. Calistri D, Presciuttini S, Buonsanti G, et al. 2000. Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition. Int. J. Cancer 89: 87-91
70. Debniak T, Kurzawski G, Gorski B, et al. 2000. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur. J. Cancer 36:49-54
71. Loukola A, Eklin K, Laiho P, et al. 2001. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res. 61:4545-49
72. Liu T, Wahlberg S, Burek E, et al. 2000. Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer 27:17-25
73. Ruszkiewicz A, Bennett G, Moore J, et al. 2002. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 34:541-47
74. Lindor NM, Burgart LJ, Leontovich O, et al. 2002. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J. Clin. Oncol. 20:1043-48
75. Christensen M, Katballe N, Wikman F, et al. 2002. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer 95:2422-30
76. Grady WM. 2003. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining. Arch. Pathol. Lab. Med. 127:694-700
77. Powell SM. 2002. Direct analysis for familial adenomatous polyposis mutations. Mol. Biotechnol. 20:197-207
78. Liu B, Parsons R, Papadopoulos N, et al. 1996. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat. Med. 2:169-74
79. Renkonen E, Zhang Y, Lohi H, et al. 2003. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J. Clin. Oncol. 21:3629-37
80. Kohonen-Corish M, Ross VL, Doe WF, et al. 1996. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am. J. Hum. Genet. 59:818-24
81. Yan H, Papadopoulos N, Marra G, et al. 2000. Conversion of diploidy to haploidy. Nature 403:723-24
82. Gazzoli I, De Andreis C, Sirchia SM, et al. 1996. Molecular screening of families affected by familial adenomatous polyposis (FAP). J. Med. Screen. 3:195-99
83. Hayes VM, Kotze MJ, Grobbelaar JJ, et al. 1996. Presymptomatic diagnosis of familial adenomatous polyposis using intragenic polymorphisms and CA repeats flanking the APC gene. Genet. Counseling 7:1-7
84. de la Chapelle. 2003. Inherited human diseases: victories, challenges, disappointments. Am. J. Hum. Genet. 72:236-40
85. Ramsey SD, Clarke L, Etzioni R, et al. 2001. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann. Intern. Med. 135:577-88
86. Ramsey SD, Burke W, Clarke K. 2003. An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer. Genet. Med. 5:353-63
87. Jarvinen HG, Aarnio M, Mustonen H, et al. 2000. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-34
88. Loader S, Shields C, Levenkron JC, et al. 2002. Patient vs. physician as the target for educational outreach about screening for an inherited susceptibility to colorectal cancer. Genetic Testing 6:281-90